164 related articles for article (PubMed ID: 3710065)
1. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
[TBL] [Abstract][Full Text] [Related]
2. Determinants of drug disposition in patients with cirrhosis.
Huet PM; Villeneuve JP
Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
[TBL] [Abstract][Full Text] [Related]
3. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
Huet PM; Lelorier J
Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
[TBL] [Abstract][Full Text] [Related]
4. Drug disposition in patients with HBsAg-positive chronic liver disease.
Villeneuve JP; Thibeault MJ; Ampelas M; Fortunet-Fouin H; LaMarre L; Côté J; Pomier-Layrargues G; Huet PM
Dig Dis Sci; 1987 Jul; 32(7):710-4. PubMed ID: 3595383
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt.
Pomier-Layrargues G; Huet PM; Infante-Rivard C; Villeneuve JP; Marleau D; Duguay L; Tanguay S; Lavoie P
Hepatology; 1988; 8(6):1506-10. PubMed ID: 3192163
[TBL] [Abstract][Full Text] [Related]
6. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
Gugler R; Lain P; Azarnoff DL
J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
[TBL] [Abstract][Full Text] [Related]
7. Assessment of liver function by the aminopyrine breath test.
Villeneuve JP; Arsène D; Huet PM
Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
[TBL] [Abstract][Full Text] [Related]
8. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
10. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
[TBL] [Abstract][Full Text] [Related]
11. The portacaval and splenocaval shunt in the normal rat. A morphometric and functional reevaluation.
Schröder R; Müller O; Bircher J
J Hepatol; 1985; 1(2):107-23. PubMed ID: 4056341
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?
Ott P; Clemmesen O; Keiding S
Dig Dis Sci; 2000 Feb; 45(2):359-65. PubMed ID: 10711452
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
Zito RA; Reid PR
J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
[TBL] [Abstract][Full Text] [Related]
14. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F
Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779
[TBL] [Abstract][Full Text] [Related]
16. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis.
Colli A; Buccino G; Cocciolo M; Parravicini R; Scaltrini G
Clin Pharmacol Ther; 1988 Dec; 44(6):642-9. PubMed ID: 3197365
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
[TBL] [Abstract][Full Text] [Related]
18. Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity.
Lauterburg BH; Sautter V; Preisig R; Bircher J
Gastroenterology; 1976 Aug; 71(2):221-7. PubMed ID: 939381
[TBL] [Abstract][Full Text] [Related]
19. Effect of endotoxin shock on the clearance of lidocaine and indocyanine green in the perfused rat liver.
McKindley DS; Chichester C; Raymond R
Shock; 1999 Dec; 12(6):468-72. PubMed ID: 10588516
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.
Merkel C; Bolognesi M; Finucci GF; Angeli P; Caregaro L; Rondana M; Gatta A
J Hepatol; 1989 Jul; 9(1):16-22. PubMed ID: 2768794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
